Caraway Therapeutics, Inc.
BioTech/Drugs - Cambridge, MA, US
Caraway Therapeutics, Inc. Employees
Caraway Therapeutics, Inc. Senior Management
Caraway Therapeutics, Inc. Details
A TARGETED APPROACH TO ACTIVATE CELLULAR CLEARANCECaraway's therapeutic approach leverages genetic data and unique biological understanding to develop proprietary small molecules that activate cellular clearance and recycling processes – accelerating clearance of accumulated toxic materials and defective cellular components. New insights in genetics highlight the link between lysosomal function and pathologies in multiple organ systems, including the central nervous system (CNS), heart, kidney, and muscle. Caraway is a leader in targeting these mechanisms with potentially disease-modifying compounds for patients suffering the devastating effects of neurodegenerative and rare diseases including Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), and lysosomal storage diseases (LSDs).
Caraway Therapeutics, Inc. Technologies
Email Providers
Outlook
CMS
WordPress.org
Fonts
Google Font API
Hosting
Amazon AWS